Literature DB >> 15016239

Recent advances in the treatment of childhood obesity.

R M Suskind1, U Blecker, J N Udall, T K von Almen, H D Schumacher, L Carlisle, M S Sothern.   

Abstract

The rapid increase in the prevalence of obesity in the last decade indicates a need for effective treatment programs. We conducted a short-term, repeated-measures, clinical-outcome trial in three groups of children and adolescents in two different locations. Two cohorts (n=34) were enrolled in a 36-wk multi-disciplinary weight-management program at the Children's Hospital of New Orleans. One cohort (n=16) was enrolled in a similar intervention at the General Clinical Research Center (GCRC) at the Medical Center of Louisiana for a 10-wk summer weight-loss program. Subjects were offered a protein-sparing modified fast (PSMF) diet (600-800 kcal/d; 2 g protein/kg body weight), followed by a balanced hypocaloric diet, and they participated in behavior-modification sessions and a moderate-intensity (45-55% volume of oxygen consumed at maximal effort [VO(2)max]), progressive exercise program. The following parameters were examined at baseline, 10 wk, and 36 wk (cohort 1 only): Weight, height, percentage of ideal body weight (%IBW), relative body fat (%fat), fat free body (FFB) mass, estimated VO(2)max mL/kg min(BW) [adjusted for body weight]), blood chemistries, lipid profiles (total cholesterol [TC], triglycerides [TG], low-density lipoprotein [LDL], high-density lipoprotein [HDL], and insulin-like growth factor-1 [IGF-1]). All three groups experienced significant decreases in weight, %IBW and %fat at 10 wk. The weight loss was maintained at 26 wk in cohorts 1 and 2, and at 36 wk in cohort 1. There were no significant decreases in height velocity during the study. In addition, measures of estimated VO(2)max mL/kg/min(BW) and IGF-1 parameters were significantly greater at 10 wk compared to baseline. Measures of TC, TG, and LDL were significantly lower at 10 wk, with no significant changes noted in HDL. We conclude that a multi-disciplinary weight-management program, including PSMF, behavior modification, and exercise, provides an effective method of treatment for obesity in children and adolescents. Long-term, randomized, and controlled clinical trials are needed to confirm the results of this preliminary, short-term observation.

Entities:  

Year:  2000        PMID: 15016239     DOI: 10.1034/j.1399-5448.2000.010105.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  8 in total

1.  Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents.

Authors:  Nancy F Krebs; Dexiang Gao; Jane Gralla; Juliet S Collins; Susan L Johnson
Journal:  J Pediatr       Date:  2010-03-20       Impact factor: 4.406

2.  Effect of a 3-week body mass reduction program on body composition, muscle function and motor performance in pubertal obese boys and girls.

Authors:  N A Maffiuletti; A De Col; F Agosti; S Ottolini; D Moro; M Genchi; M Massarini; C L Lafortuna; A Sartorio
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents.

Authors:  Sophie Deram; Christiane Y Nicolau; Pablo Perez-Martinez; Isabel Guazzelli; Alfredo Halpern; Bernardo L Wajchenberg; Jose M Ordovas; Sandra M Villares
Journal:  J Clin Endocrinol Metab       Date:  2008-09-23       Impact factor: 5.958

Review 4.  Childhood obesity for pediatric gastroenterologists.

Authors:  Jeannie S Huang; Sarah E Barlow; Ruben E Quiros-Tejeira; Ann Scheimann; Joseph Skelton; David Suskind; Patrika Tsai; Victor Uko; Joshua P Warolin; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-01       Impact factor: 2.839

5.  Rationale and design of a pilot study to evaluate the acceptability and effectiveness of a revised protein sparing modified fast (rPSMF) for severe obesity in a pediatric tertiary care weight management clinic.

Authors:  I U Eneli; R P Watowicz; J Xu; A Tindall; M Walston; K Tanner; J Worthington; K J Pratt
Journal:  Contemp Clin Trials Commun       Date:  2019-05-27

6.  Using a Revised Protein-Sparing Modified Fast (rPSMF) for Children and Adolescents with Severe Obesity: A Pilot Study.

Authors:  Ihuoma Eneli; Jinyu Xu; Alexis Tindall; Rosanna Watowicz; Jennifer Worthington; Kelly Tanner; Keeley Pratt; Marnie Walston
Journal:  Int J Environ Res Public Health       Date:  2019-08-23       Impact factor: 3.390

Review 7.  Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment.

Authors:  Yoojin Lindsey Chung; Young-Jun Rhie
Journal:  J Obes Metab Syndr       Date:  2021-12-30

8.  Adolescents' and Parents' Perspectives of a Revised Protein-Sparing Modified Fast (rPSMF) for Severe Obesity.

Authors:  Keeley Pratt; Jennifer Cotto; Jinyu Xu; Rosanna Watowicz; Marnie Walston; Ihuoma Eneli
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.